Rice method opens pathway to new drugs and dyes

Editor’s note: Links to images for download appear at the end of this release.

David Ruth
713-348-6327
david@rice.edu

Mike Williams
713-348-6728
mikewilliams@rice.edu

Rice method opens pathway to new drugs and dyes

Rice University chemists work to streamline synthesis of cancer-fighting and other compounds 

HOUSTON – (Sept. 1, 2015) – Rice University scientists have developed a practical method to synthesize chemical building blocks widely used in drug discovery research and in the manufacture of drugs and dyes.

The new method from the lab of Rice synthetic chemist K.C. Nicolaou was designed to enable the discovery and development of novel drugs to attack cancer cells and as an efficient way to create new molecular entities for biology and medicine.

The research appears in the international edition of Angewandte Chemie.

The Nicolaou lab specializes in synthesizing substances found in nature that have useful properties but are too scarce to harvest from their natural sources to test, let alone use in clinical or other settings. Nicolaou is best known for being the first to synthesize the powerful anti-cancer drug taxol and more recently achieved the total synthesis of the cancer-fighting compound shishijimicin A.

The new method’s primary product is an anthraquinone, a structural motif found in many dyes (usually red) and certain medications. The anthraquinone is a simple three-ringed molecule of carbon, hydrogen and oxygen atoms. The Rice researchers discovered a practical and versatile way to synthesize amino- and methoxyphenolic anthraquinones, more complex structures needed for the development of drugs and other compounds.

The researchers are using their method to synthesize natural and designed biologically active molecules, including uncialamycin, a potent antibiotic and anti-cancer agent first discovered in a strain of streptomycete bacteria residing in a marine creature. Uncialamycin was first synthesized by the Nicolaou lab in 2007.

“This is a practical, very general method that allows us a way to make all kinds of natural products and their variations, which is important in drug discovery,” Nicolaou said. “Uncialamycin and its analogs are examples of the many applications we envision for this method.”

Nicolaou sees hope for the efficient production of uncialamycin for possible clinical use against cancer. If the drug can be successfully attached to antibodies that target tumor cells, it can invade the cells and destroy their DNA, he said.

“This is one of the most important anti-cancer agents found in nature in recent times,” he said. “The antibodies can deliver this toxin specifically to cancer cells, and they become Trojan horses. They’re sucked inside and kill the cell. So there’s a lot of interest in these compounds.”

Nicolaou said the drive and the challenges to find new drugs often results in methods with great potential. “If we can’t find a method in the chemical repertoire to solve a problem, we’re forced to create a new one,” he said. “Every molecule provides a different challenge to a synthetic chemist. We see these challenges as opportunities to develop methods that everybody can use.”

Postdoctoral researchers Min Lu and Akshay Shah and graduate student Pengxi Chen, all of Rice, co-authored the paper. Nicolaou is Rice’s Harry C. and Olga K. Wiess Professor of Chemistry.

Bristol-Myers Squibb, the Cancer Prevention and Research Institute of Texas and the Welch Foundation supported the research.

-30-

Read the abstract at http://onlinelibrary.wiley.com/doi/10.1002/anie.201507007/abstract

Follow Rice News and Media Relations via Twitter @RiceUNews

Related Materials:

Nicolaou bio: http://chemistry.rice.edu/FacultyDetail.aspx?p=736D6ADC0CF5EA6C

Wiess School of Natural Sciences: http://naturalsciences.rice.edu

Images for download:

 

 

 

 

 

 

https://news2.rice.edu/files/2015/08/0831_SYNTHESIS-1-WEB.jpg

The chemical structure of uncialamycin, a compound found in nature and synthesized by Rice University synthetic chemist K.C. Nicolaou, is one target of a new method to simplify the manufacture of drugs and other compounds. The method is based on modifying the central three-ring structure at the bottom, known as an anthraquinone. (Credit: Courtesy of K.C. Nicolaou/Rice University)

 

 

 

 

 

 

 

 

https://news2.rice.edu/files/2015/08/0831_SYNTHESIS-2-WEB.jpg

K.C. Nicolaou (Credit: Jeff Fitlow/Rice University)

Located on a 300-acre forested campus in Houston, Rice University is consistently ranked among the nation’s top 20 universities by U.S. News & World Report. Rice has highly respected schools of Architecture, Business, Continuing Studies, Engineering, Humanities, Music, Natural Sciences and Social Sciences and is home to the Baker Institute for Public Policy. With 3,888 undergraduates and 2,610 graduate students, Rice’s undergraduate student-to-faculty ratio is 6-to-1. Its residential college system builds close-knit communities and lifelong friendships, just one reason why Rice is ranked No. 1 for best quality of life and for lots of race/class interaction by the Princeton Review. Rice is also rated as a best value among private universities by Kiplinger’s Personal Finance. To read “What they’re saying about Rice,” go here.

About Mike Williams

Mike Williams is a senior media relations specialist in Rice University's Office of Public Affairs.